Add Company
Join Now

Zucara Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Zucara's estimated annual revenue is currently $2.3M per year.(i)
  • Zucara's estimated revenue per employee is $211,364

Employee Data

  • Zucara has 11 Employees.(i)
  • Zucara grew their employee count by 0% last year.

Zucara's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Co Founder & Chief Scientific OfficerReveal Email/Phone
3
Manager, Scientific ProgramsReveal Email/Phone
4
ChairmanReveal Email/Phone
5
Directory, Clinical & Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M4018%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.3M17-15%N/AN/A
#4
$2.6M176%N/AN/A
#5
$12.9M835%N/AN/A
#6
$1.9M244%$89.5MN/A
#7
$2.8M186%N/AN/A
#8
$40.3M26021%N/AN/A
#9
$0.9M60%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is Zucara?

Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life..

keywords:N/A

N/A

Total Funding

11

Number of Employees

$2.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zucara News

2022-04-17 - Somatostatin Receptor Type 2 Market – Major Technology ...

Amryt Pharma plc, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Ipsen SA, Progenics Pharmaceuticals Inc, Strongbridge Biopharma plc, Zucara...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M11-91%$21M
#2
$1M11-21%N/A
#3
$3.5M11-45%$5.3M
#4
$1M11N/AN/A
#5
$1M11N/AN/A